[Double-blind study of the efficacy of tetrabamate and tiapride in the treatment of alcohol deprivation syndrome].
D000328:Adult; D001463:Barbiturates / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000627:therapeutic use*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D013976:Tiapamil Hydrochloride / Q000627:therapeutic use*
D001463:Barbiturates; D001549:Benzamides; D004338:Drug Combinations; D011619:Psychotropic Drugs; D000431:Ethanol; C006648:difebarbamate, febarbamate, phenobarbital drug combination; D013976:Tiapamil Hydrochloride; D010634:Phenobarbital
Estudio a doble ciego de la eficacia del tetrabamato y el tiapride en el tratamiento del síndrome de deprivación alcohólica.